Form 4: Oncocyte Corp CEO Josh Riggs Acquires Additional Shares in Private Offering

Oncocyte Corp CEO and President Josh Riggs purchased 3,390 shares of the company's common stock at $2.95 per share in a private offering on April 11, 2024.

Summary

• On April 11, 2024, Josh Riggs, the CEO and President of Oncocyte Corp, acquired 3,390 shares of the company's common stock.
• The shares were purchased at a price of $2.95 per share in a private offering.
• Following the transaction, Riggs directly owns 3,505 shares of Oncocyte Corp.
• This transaction was reported on April 15, 2024.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the CEO's purchase of shares signals confidence in the company, but the amount is not substantial enough to be overwhelmingly positive.

Positives

• The CEO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by the CEO is generally viewed positively.

Stakeholder Impact

• The purchase may positively influence shareholder sentiment.

Key Dates